| 17-Jun-13 06:24PM | [$$] Can Green Mountain Coffee and 4 Biotechs Climb? at Barrons.com |
| 09:00AM | Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs at Minyanville |
| 14-Jun-13 08:44AM | For Love And Money: 3 Growth Stocks From Casey's Alex Daley at Seeking Alpha |
| 09-Jun-13 10:25PM | SmithOnStocks Opines: June 9, 2013 at Seeking Alpha |
| 07-Jun-13 09:23AM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +7.20% |
| 06:00AM | InPlay: ImmunoCellular Therapeutics announces recommendation of data monitoring committee to continue ict-107 phase ii trial following interim analysis; study completion anticipated by YE 2013 Briefing.com |
| 06:00AM | ImmunoCellular Therapeutics Announces Recommendation of Data Monitoring Committee to Continue ICT-107 Phase II Trial Following Interim Analysis Business Wire |
| 03-Jun-13 07:30AM | NeoStem's Subsidiary, PCT, Enters Into a Manufacturing Agreement With ImmunoCellular Therapeutics, Ltd. for Dendritic Cell Vaccines Targeting Brain and Other Cancers GlobeNewswire |
| 30-May-13 11:48AM | DelMar Pharmaceuticals To Present Updated Phase I GBM Data At ASCO at Seeking Alpha |
| 22-May-13 06:00AM | ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on May 30th Business Wire |
| 20-May-13 04:01PM | IMUC July Options Begin Trading at TheStreet |
| 17-May-13 01:04PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Financials EDGAR Online Financials |
| 16-May-13 06:01AM | InPlay: ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target Briefing.com |
| 06:00AM | ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target Business Wire |
| 14-May-13 11:05PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem EDGAR Online |
| 08:16AM | 3 Biotech Stocks With Potential at Seeking Alpha |
| 10-May-13 02:56PM | ImmunoCellular Therapeutics: Marching Toward Top Line Data For ICT-107 In Q4 2013 at Seeking Alpha |
| 09-May-13 11:02PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04:00PM | ImmunoCellular Therapeutics Announces First Quarter 2013 Financial Results Business Wire |
| 07:07AM | Q1 2013 IMMUNOCELLULAR THERAPEUTICS Earnings Release - After Market Close CCBN |
| 07-May-13 08:23PM | Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trials at Seeking Alpha |
| 03-May-13 12:15PM | Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial at Seeking Alpha |
| 01-May-13 10:37AM | With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curse at Seeking Alpha -6.35% |
| 06:00AM | ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013 Business Wire |
| 18-Apr-13 09:11AM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statement EDGAR Online |
| 15-Apr-13 06:56AM | 2 Undervalued Immunotherapy Picks at Seeking Alpha |
| 08-Apr-13 12:16PM | The 9 Levels Of Biotechnology And Who Should Invest: Part 2 at Seeking Alpha |
| 28-Mar-13 06:00AM | ImmunoCellular Therapeutics to Present at Future Leaders Conference on April 5th Business Wire |
| 27-Mar-13 11:51AM | Biotechnology Super Panel Talks Development, Marketing And The Future at Seeking Alpha |
| 10:32AM | ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107 at Seeking Alpha |
| 15-Mar-13 01:04PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Financials EDGAR Online Financials |
| 11-Mar-13 05:12PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-K, Annual Report EDGAR Online |
| 04:35PM | ImmunoCellular Therapeutics to Present at ROTH Conference on March 18th Business Wire |
| 10-Mar-13 06:08AM | The Weekend Blitz: A Discussion Of Investment Strategies And Investment Ideas at Seeking Alpha |
| 08-Mar-13 06:00AM | Biotech Stock Mailbag: Celldex, TG Therapeutics, Sarepta at TheStreet |
| 07-Mar-13 09:49AM | ImmunoCellular Update Adds Clarity And Further Validates Investment Thesis at Seeking Alpha |
| 08:15AM | NW Bio Provides Guidance On Phase III Trial Enrollment Timing: Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials PR Newswire |
| 05-Mar-13 10:05PM | ImmunoCellular Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha +6.06% |
| 07:29PM | 2 Biotech Superstars For 2013 at Seeking Alpha |
| 04:03PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem EDGAR Online |
| 04:00PM | ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results Business Wire |
| 04-Mar-13 01:52PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events EDGAR Online |
| 10:04AM | A Comprehensive Look At Immunotherapy - Part 2 at Seeking Alpha |
| 06:04AM | InPlay: ImmunoCellular Therapeutics announces issuance of key patent for ICT-121 cancer vaccine Briefing.com |
| 06:00AM | ImmunoCellular Therapeutics Announces Issuance of Key Patent for ICT-121 Cancer Vaccine Business Wire |
| 26-Feb-13 03:49PM | Correctly Reading Cash Flows And Balance Sheets: ImmunoCellular Vs. Northwest at Seeking Alpha |
| 06:00AM | ImmunoCellular Therapeutics to Report Financial Results for the Fourth Quarter and Full Year 2012 on March 5, 2013 Business Wire |
| 25-Feb-13 02:37PM | Northwest Biotherapeutics: My Rationale For Having A Buy Recommendation at Seeking Alpha |
| 10:28AM | The Monday Morning Quarterback at Seeking Alpha |
| 20-Feb-13 08:20AM | Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success Marketwire -6.46% |
| 19-Feb-13 03:23AM | Northwest Biotherapeutics: A Critique Of Adam Feuerstein Of The Street.com's Attack Job at Seeking Alpha |
| 12-Feb-13 11:22AM | A Look At ImmunoCellular Therapeutics Just Prior To Interim Data at Seeking Alpha +6.72% |
| 08-Feb-13 11:12AM | A Comprehensive Look At Immunotherapy With Analyst/Immunologist Dr. Rahul Jasuja at Seeking Alpha -5.56% |
| 06:30AM | Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics at TheStreet |
| 06-Feb-13 08:25AM | 3 Biopharma Catalyst Trades To Consider For Today at Seeking Alpha +13.11% |
| 05-Feb-13 02:19PM | 3 Stocks Under $5 Making Big Moves at TheStreet +12.44% |
| 04-Feb-13 04:00PM | ImmunoCellular Therapeutics to Present at BIO CEO & Investor Conference on February 11th Business Wire |
| 01-Feb-13 11:23AM | Investors Discounting Positive Data Readout On Brain Cancer Studies at Seeking Alpha |
| 31-Jan-13 02:40PM | 2 Small-Cap Biotechs With Zero Debt And Potentially Beneficial Long-Term Catalysts at Seeking Alpha |
| 30-Jan-13 01:31PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events EDGAR Online |
| 29-Jan-13 06:01AM | InPlay: ImmunoCellular Therapeutics' investigational new drug application for ICT-140 allowed by the FDA Briefing.com |
| 06:00AM | ImmunoCellular Therapeutics Investigational New Drug (IND) Application for ICT-140 Allowed by the FDA Business Wire |
| 17-Jan-13 08:20AM | Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements Marketwire |
| 07-Jan-13 06:10AM | InPlay: ImmunoCellular Therapeutics provides update on corporate milestone; A total of 278 patients have been enrolled at 25 centers in the US, and 124 patients have been treated in Phase IIb randomized, placebo-controlled, double-blind cli Briefing.com |
| 06:00AM | ImmunoCellular Therapeutics Provides Update on Corporate Milestones Business Wire |
| 02-Jan-13 04:03PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +5.73% |
| 08:02AM | The Twitterverse's Biotech Stock Picks for 2013 at TheStreet |
| 06:00AM | ImmunoCellular Therapeutics Appoints Gary S. Titus to its Board of Directors Business Wire |
| 19-Dec-12 01:30PM | 7 Companies Fighting To Cure Cancer at Seeking Alpha |
| 06-Dec-12 06:02AM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 04-Dec-12 01:06PM | ImmunoCellular Shares Near Lows Offer A Speculative Oncology Play at Seeking Alpha |
| 12:20PM | Tuesdays biggest movers; Macau scrutiny hits Wynn at MarketWatch |
| 09:22AM | Tuesdays biggest gaining and declining stocks at MarketWatch |
| 03-Dec-12 06:51PM | ImmunoCellular Therapeutics names Gengos as CEO AP |
| 06:02PM | ImmunoCellular Therapeutics names Gengos as CEO AP |
| 04:00PM | InPlay: ImmunoCellular Therapeutics appoints Andrew Gengos as Chief Executive Officer Briefing.com |
| 04:00PM | ImmunoCellular Therapeutics Appoints Andrew Gengos as Chief Executive Officer Business Wire |
| 21-Nov-12 08:49AM | ImmunoCellular Therapeutics: An Opportunity For Great Upside Potential at Seeking Alpha |
| 19-Nov-12 08:30AM | Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire +5.62% |
| 08:20AM | Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire |
| 16-Nov-12 01:04PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Financials EDGAR Online Financials +7.23% |
| 13-Nov-12 09:30AM | New Star Analyst Rankings for ImmunoCellular Therapeutics, Lt StarMine |
| 12-Nov-12 08:32AM | PropThink: Galena: One of Biotech's Most Vulnerable Names Thomson Reuters ONE -5.08% |
| 06:00AM | ImmunoCellular Therapeutics Reports Third Quarter 2012 Financial Results Business Wire |
| 09-Nov-12 04:54PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 05-Nov-12 06:00AM | ImmunoCellular Therapeutics to Present at Lazard Capital Markets 9th Annual Healthcare Conference on November 14th Business Wire |
| 01-Nov-12 08:20AM | FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases Marketwire +6.15% |
| 06:01AM | InPlay: ImmunoCellular Therapeutics provides update on recent 2012 achievements and anticipated milestones; Phase IIb randomized, placebo-controlled, double-blind clinical trial of ICT-107 is progressing well Briefing.com |
| 06:00AM | ImmunoCellular Therapeutics Provides an Update on Recent 2012 Achievements and Anticipated Milestones Business Wire |
| 19-Oct-12 07:15AM | Healthcare Business Update: Pfizer Gets New Results, Novovax Studies Meet Goals at Wall St. Cheat Sheet |
| 06:02AM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Finan EDGAR Online |
| 18-Oct-12 06:04PM | Healthcare Business Update: Pfizer Gets New Results, Novovax Studies Meet Goals at Wall St. Cheat Sheet -14.11% |
| 05:23PM | IMMUNOCELLULAR THERAPEUTICS, LTD. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 01:44PM | Attack of the Creeping Share Count at Motley Fool |
| 09:13AM | InPlay: ImmunoCellular Therapeutics, Ltd. announces pricing of its previously announced public offering of common stock and warrants of $2.10/share Briefing.com |
| 09:12AM | ImmunoCellular Therapeutics, Ltd. Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants Business Wire |
| 17-Oct-12 04:02PM | InPlay: ImmunoCellular Therapeutics Announces Proposed Public Offering of Common Stock and Warrants; size not disclosed Briefing.com |
| 04:01PM | ImmunoCellular Therapeutics, Ltd. Announces Proposed Public Offering of Common Stock and Warrants Business Wire |
| 05-Oct-12 08:30AM | Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire |
| 08:25AM | Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire |
